Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant public health concern globally. This article aims to provide an overview of the latest advancements in the diagnosis and treatment of enteric fever.
Traditional diagnostic methods, such as blood cultures, have limitations including time-consumption and low sensitivity. Recent advancements include the development of molecular techniques like Polymerase Chain Reaction (PCR) and Loop-Mediated Isothermal Amplification (LAMP). These techniques offer higher sensitivity and specificity, and faster results, contributing to improved patient management.
Antimicrobial resistance has complicated the treatment of enteric fever. The introduction of newer antibiotics such as azithromycin and third-generation cephalosporins (e.g., ceftriaxone) has proven effective. Additionally, the resurgence of older antibiotics like chloramphenicol, following sensitivity restoration, demonstrates the dynamic nature of antimicrobial resistance.
Vaccination remains a cornerstone in the prevention of enteric fever. The World Health Organization (WHO) has endorsed the use of Typhoid Conjugate Vaccines (TCVs), given their longer-lasting immunity, suitability for children under two, and single-dose administration. This advancement has the potential to significantly reduce the global burden of enteric fever.
The fight against enteric fever is being bolstered by advancements in diagnostic techniques, treatment strategies, and preventive measures. Continued research and development are crucial to stay ahead of the evolving pathogen and antimicrobial resistance. As healthcare professionals, staying abreast of these advancements is essential to provide optimal patient care and contribute to global health improvement.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Year in Review: Non-Small Cell Lung Cancer
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML
1.
Targeted Therapies for Breast Cancer: What’s New?
2.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Sorafenib: Understanding the science behind a powerful cancer drug
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Common Cancer Myths Debunked
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation